{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:47:31Z","timestamp":1792450051579,"version":"4.5.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00428-021-03077-7","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T08:02:53Z","timestamp":1615795373000},"page":"1047-1050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["CD146 immunohistochemical staining for the separation of benign from malignant mesothelial proliferations"],"prefix":"10.1007","volume":"479","author":[{"given":"Taylor","family":"Salisbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4851-8517","authenticated-orcid":false,"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"key":"3077_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.5858\/arpa.2012-0112-RA","volume":"136","author":"A Churg","year":"2012","unstructured":"Churg A, Galateau-Salle F (2012) The separation of benign from malignant mesothelial proliferations. Arch Pathol Lab Med 136:1217\u20131226","journal-title":"Arch Pathol Lab Med"},{"key":"3077_CR2","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1097\/PAS.0000000000001565","volume":"44","author":"A Churg","year":"2020","unstructured":"Churg A, Naso JR (2020) The separation of benign and malignant mesothelial proliferations: new markers and how to use them. Am J Surg Pathol 44:e100\u2013e112","journal-title":"Am J Surg Pathol"},{"key":"3077_CR3","first-page":"3871","volume":"19","author":"G Zhang","year":"2020","unstructured":"Zhang G, Yang DL, Zheng G, Liang Y (2020) Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma. Oncol Lett 19:3871\u20133880","journal-title":"Oncol Lett"},{"key":"3077_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41392-020-00259-8","volume":"5","author":"Z Wang","year":"2020","unstructured":"Wang Z, Xu Q, Zhang N, Du X, Xu G, Yan X (2020) CD146, from a melanoma cell adhesion molecule to a signaling receptor. Sig Transduction Targeted Ther 5:148","journal-title":"Sig Transduction Targeted Ther"},{"key":"3077_CR5","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-08-1363","volume":"69","author":"S Bidlingmaier","year":"2009","unstructured":"Bidlingmaier S, He J, Wang Y, An F, Feng J, Barbone D, Gao D, Franc B, Broaddus VC, Liu B (2009) Identification of MCAM\/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma. Cancer Res 69:1570\u20131577","journal-title":"Cancer Res"},{"key":"3077_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1309\/AJCP5KNL7QTELLYI","volume":"141","author":"H Minato","year":"2014","unstructured":"Minato H, Kurose N, Fukushima M, Nojima T, Usuda K, Sagawa M, Sakuma T, Ooi A, Matsumoto I, Oda M, Arano Y, Shimizu J (2014) Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells. Am J Clin Pathol 141:85\u201393","journal-title":"Am J Clin Pathol"},{"key":"3077_CR7","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/modpathol.2010.134","volume":"23","author":"A Sato","year":"2010","unstructured":"Sato A, Torii I, Okamura Y, Yamamoto T, Nishigami T, Kataoka TR, Song M, Hasegawa S, Nakano T, Kamei T, Tsujimura T (2010) Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium. Mod Pathol 23:1458\u20131466","journal-title":"Mod Pathol"},{"key":"3077_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/jclinpath-2015-203211","volume":"69","author":"T Kawai","year":"2016","unstructured":"Kawai T, Tominaga S, Hiroi S, Ogata S, Nakanishi K, Kawahara K, Sonobe H, Hiroshima K (2016) Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses. J Clin Pathol 69:706\u2013712","journal-title":"J Clin Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03077-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03077-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03077-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T02:02:50Z","timestamp":1636336970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-021-03077-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["3077"],"URL":"https:\/\/doi.org\/10.1007\/s00428-021-03077-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"22 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Committee on Human Research Ethics by the University of British Columbia and Vancouver General Hospital","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}